You are here

Approval of updated storage conditions for the Pfizer COVID-19 vaccine

8 April 2021

The TGA has received and assessed additional data submitted by Pfizer for their COVID-19 vaccine (COMIRNATY - BNT162b2). A storage condition of ‑ 20±5°C for up to 2 weeks (even during transportation) within the 6 month shelf life when stored at -90 to -60°C has been approved.  An updated Product Information sheet is anticipated to be submitted by Pfizer and published on our website shortly.


Update:

Storage and transportation conditions for the Pfizer COVID-19 vaccine – media release published 8 April 2021.